Increased oxidative stress in adult women with iron deficiency anemia

Paternostro R, Kapzan L, Mandorfer M, et al. Anemia and iron deficiency in compensated and decompensated cirrhosis: prevalence and impact on clinical outcomes. J Gastroenterol Hepatol 2020; 35: 1619-27. doi:10.1111/jgh.14988.

Owaidah T, Al-Numair, N, Al-Suliman A, et al. Iron deficiency and iron deficiency anemia are common epidemiological conditions in Saudi Arabia: report of the National Epidemiological Survey. Anemia 2020;Article ID 6642568. doi: 10.1155/2020/6642568.

Gardner W, Kassebaum N. Global, regional, and national prevalence of anemia and its causes in 204 countries and territories, 1990–2019. Curr Dev Nutr 2020;4:830. doi:10.1093/cdn/nzaa053_035.

Hall JE, Hall ME. Guyton & Hall Textbook of Medical Physiology_3rd SAE-E-book: Third South Asia Edition. Adaption Editor: Vaz M, Kurpad A, Raj T. New Delhi, India : Elsevier, Inc.; 2021.

Abbaspour N, Hurrell R, Kelishadi R. Review on iron and its importance for human health. J Res Med Sci 2014;19:164–74.

Cronin SJF, Woolf CJ, Weiss G, Penninger JM. The role of iron regulation in immunometabolism and immune-related disease. Front Mol Biosci 2019;6:116. doi:10.3389/fmolb.2019.00116.

Alkadi H. A review on free radicals and antioxidants. Infect Disord Drug Targets 2020;20:16-26. doi: 10.2174/ 1871526518666180628124323.

Andries A, Rozenski J, Vermeersch P, Mekahli D, Van Schepdael A. Recent progress in the LC-MS/MS analysis of oxidative stress biomarkers. Electrophoresis 2021;42:402-28. doi: 10.1002/elps.202000208.

Dogru A, Nazýroglu M, Cig B. Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study. Arch Med Sci 2019;15:1415–24. doi:10.5114/aoms.2018.79485.

Gedik AH, Çakir E, Vehapoðlu Türkmen A, Özer OF, Kaygusuz SB. Total oxidant and antioxidant status and paraoxonase 1 levels of children with non-cystic fibrosis bronchiectasis. Turk J Med Sci 2020;50:1-7. doi:10.3906/sag1503-99.

Jansen E, Ruskovska T. Serum biomarkers of (anti)oxidant status for epidemiological studies. Int J Mol Sci 2015;16:27378–90. doi:10.3390/ijms161126032

Ndrepepa G. Myeloperoxidase - a bridge linking inflammation and oxidative stress with cardiovascular disease. Clinica Chimica Acta 2019;493:36-51. doi: 10.1016/j.cca.2019.02.022.

Hawkins CL, Davies MJ. Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage. Free Radical Biol Med 2021;172:633-51. doi: 10.1016/j.freeradbiomed.2021.07.007.

Davies MJ. Myeloperoxidase: mechanisms, reactions and inhibition as a therapeutic strategy in inflammatory diseases. Pharmacol Ther 2021;218:107685. doi:10.1016/j.pharmthera.2020. 107685.

Teiber JF, Kramer GL, Haley RW. Methods for measuring serum activity levels of the 192 Q and R isoenzymes of paraoxonase 1 in QR heterozygous individuals. Clin Chem 2013;59: 1251-9. doi: 10.1373/clinchem.2012. 99331.

Okuturlar Y, Gedikbasi A, Akalin N, et al. Serum paraoxonase 1 activity in patients with iron deficiency anemia. Arch Med Sci 2016;12:697-703. doi: 10.5114/aoms.2015.48730.

Sharma R, Nachane H. Oxidative stress in iron deficiency anemia- a gender-based analysis - a pilot study. J Evolution Med Dent Sci 2020;9:3739-42. doi:10.14260/jemds/2020/821.

Aslan M, Horoz M, Çelik H. Evaluation of oxidative status in iron deficiency anemia through total antioxidant capacity measured using an automated method. Turk J Hematol 2011;28:42-6. doi: 10.5152/tjh.2011.04.

Calim A, Kanat E, Mazi EE, Oygen S, Karabay U, Borlu F. Evaluation of in-patients with iron deficiency anemia in terms of etiology. Med Bull Sisli Etfal Hosp 2020;54:428-32. doi: 10.14744/SEMB.2018.47354.

Jimenez K, Lang M. Diagnostic approach to iron deficiency anemia. Wien Med Wochenschr 2016;166:402-10. doi: 10.1007/s10354-016-0495-5.

Chandyo RK, Henjum S, Ulak M, et al. Prevalence of anemia and iron deficiency is more common in breastfed infants than their mothers in Bhaktapur, Nepal. Eur J Clin Nutr 2016;70:456-62. doi: 10.1038/ejcn.2015.199.

Bayen S, Le Grand C, Bayen M, Richard F, Messaadi N. Anemia management in non-menopausal women in a primary care setting: a prospective evaluation of clinical practice. BMC Fam Pract 2020;21:13. doi: 10.1186/s12875-020-1086-5.

Kuyumcu F, Aycan. A. Evaluation of oxidative stress levels and antioxidant enzyme activities in burst fractures. Med Sci Monit 2018;24:225–34. doi: 10.12659/MSM.908312.

Maciejczyk M, Pliszka EH, Pietrucha B et al. Antioxidant defense, redox homeostasis, and oxidative damage in children with ataxia telangiectasia and Nijmegen breakage syndrome. Front. Immunol 2019;10:2322-33. doi:10.3389/fimmu.2019.02322.

Ayala A, Munoz MF, Argüelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014;8:360438. doi: 10.1155/2014/360438.

Gürbüz DG, Ulaº T, Paksoy F, et al. The effect of intravenous iron therapy on total antioxidant capacity in patients with iron deficiency anemia. J Clin Exper Investig 2011;2:287-91. doi: 10.5799/ahinjs.01.2011.03.0056.

Zaka-Ur-Rab Z, Adnan M, Ahmad SM, Islam N. Effect of oral iron on markers of oxidative stress and antioxidant status in children with iron deficiency anaemia. J Clin Diagnost Res 2016;10:13-9. doi: 10.7860/JCDR/2016/23601.8761.

Jankowska EA, Rozentryt P, Witkowska A, et al. Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 2011;32:1054. doi:10.1093/eurheartj/ehq158.

Madhikarmi NL, Murthy KR. Antioxidant enzymes and oxidative stress in the erythrocytes of iron deficiency anemic patients supplemented with vitamins. Iran Biomed J 2014;18:82-7. doi: 10.6091/ibj.1228.2013.

Akarsu S, Demir H, Selek S, Oguzoncul F. Iron deficiency anemia and levels of oxidative stress induced by treatment modality. Pediatr Int 2013;55:289-95. doi: 10.1111/ped.12054.

El-Shimi MS, El-Farrash RA, Ismail EA, et al. Renal functional and structural integrity in infants with iron deficiency anemia: relation to oxidative stress and response to iron therapy. Pediatr Nephrol 2015;30:1835-42. doi: 10.1007/s00467-015-3122-6.

Meneses MJ, Silvestre R, Sousa-Lima I, Macedo MP. Paraoxonase-1 as a regulator of glucose and lipid homeostasis: impact on the onset and progression of metabolic disorders. Int J Mol Sci 2019;20:4049. doi: 10.3390/ijms20164049

Meroño T, Dauteuille C, Tetzlaff W, et al. Oxidative stress, HDL functionality and effects of intravenous iron administration in women with iron deficiency anemia. Clin Nutr 2017;36:552-8. doi: 10.1016/j.clnu.2016.02.003.

Asci D, Ekerbicer N, Guvenc Demiragci Y, Yilmaz R. Oxidative stress investigation in anemia. J Health Med Nur 2020;75:16-25. doi: 10.7176/JHMN/75-03.

留言 (0)

沒有登入
gif